First-Line Lorlatinib Versus Crizotinib In Alk-Positive Non-Small Cell Lung Cancer: Asian Subgroup Analysis Of Crown Q. Zhou, H. R. Kim,R. Soo,G-C. Chang,C-H. Chiu,H. Hayashi,S-W. Kim,S. Teraoka,Y. Goto,J. Zhou,V. H. F. Lee, B. Han,J. C. M. Ho,D-W. Kim,C-C. Lin, S. Lu, A. Polli, A. M. Calella, T. S. K. Mok,Y-L. WuANNALS OF ONCOLOGY(2021)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要